A Phase 1 Study of RO4929097 (NSC749225) in Combination With Capecitabine in Refractory Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2016
At a glance
- Drugs RG 4733 (Primary) ; Capecitabine
- Indications Advanced breast cancer; Colorectal cancer; Lymphoma; Solid tumours
- Focus Adverse reactions
- 15 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Jul 2010 New trial record